Skip to main content
Rohit Bhargava on Muck Rack

Rohit Bhargava

Washington, D.C.
As seen in: LinkedIn, Medium, Forbes, Nature, Mashable, Entrepreneur, Fast Company, Inc., Substack, The BMJ and
Covers:  entrepreneurship, interviews, business strategy, marketing, social media, leadership
I help others to see the non-obvious + be more interesting. Non-Obvious Trend Curator | Listener | Storyteller | | Author | Publisher | Keynote Speaker| Dad

Get in touch with Rohit

Contact Rohit, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Rohit Bhargava’s Biography

Read Full Bio →

Rohit Bhargava is the best selling author of 4 marketing books and a Professor of Marketing at Georgetown University. He is known as a popular “non-boring” keynote speaker on the future of business, building more human brands, inspiration and leadership, social media and marketing.

His writing and interviews have appeared in Fast Company, Mashable, Forbes and dozens of online media destinations. He is a contributor to the American Express Open Forum and writes his own award winning marketing b…

Rohit Bhargava’s Journalist Portfolio

9 Ways Top Brands Use Social Media for Better Customer Service

9 Ways Top Brands Use Social Media for Better Customer Service

When an irate traveler tweeted about how he had arrived late to The Four Seasons in Palo Alto and been "bumpe…

View article →
Newsflash: No One Cares About Your Blog

Newsflash: No One Cares About Your Blog

Many brands like to treat social media like a big party at the cool kid's house. Everybody's invited, and hav…

View article →

Articles

Tumors hijack immune-privileging regulons via distinct cell types to confer T cell desertion and immunotherapy resistance across various cancers

|
By Bashir Lawal, Akshat Gupta, Renu Sharma, Huayan Ren, Rohit Bhargava, YUE WANG, Xiao-Song Wang
| Nature Verified
Abstract Immune checkpoint blockade (ICB) has transformed oncology, yet most patients fail to respond, suffer from hyper-progressive disease, or face severe immune-related toxicities, underscoring the urgent need for biomarkers that identify non-responders. Here we show that tumors co-opt an immune-privileging regulon signature (IMPREG) mirroring transcriptional programs of immune-privileged organs — to enforce T-cell desertion and ICB resistance across solid tumor types.
Open in Who Shared Issue with article?

IMIREG: a lineage-resolved regulon signature unveiling immune engagement archetypes and predicting immunotherapy response across diverse cancers

|
By Bashir Lawal, Renu Sharma, Akshat Gupta, Rohit Bhargava, Laizhi Zhang, YUE WANG, Huayan Ren, Xiao-Song Wang
| Nature Verified
Abstract A critical barrier to maximizing immune checkpoint blockade (ICB) efficacy is the lack of biomarkers that capture the core regulatory dynamics of the tumor microenvironment. We developed IMIREG, a 14-regulon transcriptional signature derived from inferred transcription factor activity that quantifies immune engagement.
Open in Who Shared Issue with article?

Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs - npj Breast Cancer

|
By Gitte Zels, Karen Van Baelen, Alexander Chang, Anirudh Pabba, Maxim De Schepper, Marion Maetens, François Richard, Josephine Van Cauwenberge, Tatjana Geukens, Kristien Borremans, Amena Mahdami, HA NGUYEN, Hà Nguyễn, ha nguyễn, Sophia Leduc, Patrick Neven, Hans Wildiers, Vincent Vandecaveye, Raphaëla Dresen, Rohit Bhargava, Tanner Bartholow, Neil M. Carleton, Ye Cao, Jie Bin Liu, Abdalla Wedn, Hunter Waltermire, Morgan Cody, Lori C. Miller, Margaret Rosenzweig, Julia Foldi, Marija Balic, Christoper Deible, Christine Hodgdon, Stephanie Walker, Adrian Lee, Steffi Oesterreich, Giuseppe Floris, Christine Desmedt, Wouter Van Den Bogaert
| Nature Verified
Abstract While primary invasive lobular carcinoma (ILC) is well characterized, metastatic ILC remains understudied. Within the post-mortem tissue donation programs, UPTIDER (Belgium) and Hope for Others (USA), we first aimed to explore intra-patient heterogeneity of key prognostic and predictive markers (stromal tumor-infiltrating lymphocytes (sTIL), estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and KI67).
Open in Who Shared Issue with article?
See all 182 licensed articles (185 Total)

Awards

Best Sales/Marketing Book of 2012 Shortlist (800CEORead) - LIKEONOMICS

2012 - Books

Thousands of business books are published each year, each with the potential to promote change and enlighten the way people think about business. Every year 800-CEO-READ recognizing the best business books of the year and the authors who committed time and energy to the books' creation.

View Award

Gold Atticus Award - PERSONALITY NOT INCLUDED

2009 - Branding

The WPP Atticus Awards honor original published thinking of relevance to marketers everywhere, written by employees of the 200+ WPP companies.

View Award